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summary
Diffuse alveolar hemorrhage (DAH) is a rare life-threatening condition which refers to the presence of red 
blood cells within alveoli deriving from hemorrhage originating in the pulmonary microvasculature. It differs 
from alveolar filling, in which blood cells derive from localized bleeding, usually of bronchial origin. DAH may 
be part of diffuse alveolar injury of any origin.
DAH should be considered a medical emergency due to the significant morbidity and mortality associated with 
respiratory failure, when secondary to impaired oxygen uptake from alveoli filled with erythrocytes.
Patients with alveolar hemorrhage present with non-specific symptoms like dyspnea, cough and hemoptysis, 
which is not always present. They may develop acutely or insidiously over a few days.
We present a case of a patient with probable Behçet’s disease complicated by pulmonary capillaritis and DAH 
resulting in refractory respiratory failure and death.
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n	 CASE REPORT
A 70-years-old Caucasian male presented 
with multiple and painful oral ulcers in-
volving soft palate, throat and tongue. He 
referred an anamnestic history of arthral-
gia, recurrent oral aphthosis, back acne 
and hemochromatosis (heterozygotes of 
H63D) with secondary hepatic cirrhosis. 
Esophago-gastro-duodenoscopy showed 
mild atrophic gastritis with intestinal meta-
plasia; ocular examinations found no evi-
dence of uveitis. 
Blood test results showed mild leukope-
nia and anemia; anti-nuclear antibodies 
(ANA), anti-exractable nuclear antigens 
(ENA) antibodies, anti-double stranded 
(ds) DNA antibodies, anti-neutrophil cyto-
plasmic antibodies (ANCA), anti-glomer-
ular basement membrane antibodies, anti-
Saccharomyces cerevisiae antibodies, and 
anti-mitochondrial antibody were negative. 
The third (C3) and fourth (C4) component 
of complement levels where normal. HLA-
B typing showed B51 and B35. Suspecting 
an incomplete Behçet’s disease, colchicine 
1 mg a day and prednisone 12.5 mg a day 
orally were started, with only slight im-
provement over 2 months.
The patient was then hospitalized for fur-
ther investigations.
On admission, his temperature was 37.8°C, 
respiratory rate 13, oxygen saturation 98% 
on air at rest, heart rate 100 bpm and blood 
pressure 150/80 mmHg. Auscultation of 
the chest revealed no pathological sign. 
Chest X-ray was normal.
Blood cell count showed mild neutrophilia 
and anemia. Erythrocyte sedimentation 
rate (ESR) was 112 mm/first hour and C-
reactive protein (CRP) 11.6 mg/dL (nor-
mal values below 15 mm/h and 0.5 mg/dL, 
respectively). Microbiological sampling 
(blood and feces cultures, throat and oral 
ulcers swabs) found no evidence of infec-
tion; search for Helicobacter pylori and 
HIV ELISA tests were negative.
Colonoscopy was delayed due to patient’s 
inability to assume bowel preparation due 
to intense oral pain.
Intravenous therapy with methylpredniso-
lone 40 mg daily was started with initial 
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healing of oral ulcers, marked reduction of 
pain, disappearance of fever.
After twelve days, oral ulcers were com-
pletely healed, patient’s conditions were 
stable, with no episode of fever.
The twelfth night, cough and chills fol-
lowed by fever (temperature up to 39°C) 
appeared. After about one hour, the patient 
complained of chest pain and dyspnea. 
Blood pressure was 75/40 and heart rate 
was 145 bpm.
Oxygen saturation on air at rest dropped 
to 84% and without improvement despite 
non-invasive ventilation with oxygen flow 
up to 15 L/min. At blood cell count hemo-
globin was 9.8 mg/dL (with a decrease of 
0.8 compared with admission) with neu-
trophilic leukocytosis (white blood cells 
24,180/µL). Chest X-ray showed right mul-
tiple patchy consolidation with pulmonary 
congestion. Attempt of tracheal intubation 
revealed presence of fresh blood in the air-
way. Within 4 hours, despite the institution 
of advanced life supports, patient’s condi-
tion kept worsening and resulted in death.
Post-mortem examination found diffuse 
blood effusion in both lungs and pleural 
cavity, with a histologic pattern of inter-
stitial edema and leak of red blood cells 
into the alveolar spaces in the context of 
pulmonary necrotizing vasculitis, involv-
ing arterioles, capillaries and venules, with 
neutrophilic infiltration (Fig. 1). No sign 
of thrombi, pulmonary artery aneurysms 
(PAA) or other pathologies were found, 
with the exception of the already known 
hepatic cirrhosis.
n	 DISCUSSION
DAH is a rare yet serious and frequently 
life-threatening complication of a variety 
of conditions, often presenting as a cata-
strophic clinical syndrome causing respi-
ratory failure, with poor outcome (1). Pa-
tients often complain of cough, dyspnea 
and hemoptysis, but it remains crucial to 
remember that even the most severe cases 
can lack the last one (2, 3). Fever, asthe-
nia and other systemic complaints may 
be present, depending on the underlying 
disease. Most patients will have crackles 
on their pulmonary examination, but the 
physical signs are usually nonspecific. 
Chest X-ray may reveal patchy alveolar 
infiltrates starting in a focal, unilateral pat-
tern and becoming diffuse with time. Com-
Figure 1 - Lung; the walls of medium sized vessels (a) and capillaries (B) showed an intense 
inflammatory infiltrate, mainly composed by granulocytes (Hematoxylin-eosin, a: 20x; B: 40x).
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puted tomography scan is more specific in 
confirming the alveolar nature and extent 
of the process and may help to assess the 
optimal site for bronchoscopy in patients 
with localized manifestations (4). Most 
commonly, the only laboratory abnormal-
ity noted in DAH patients is anemia or de-
creasing hematocrit in acute presentation. 
In any case, clinicians should assess the re-
nal function and look for signs suggestive 
of glomerulonephritis as early as possible, 
to rule out pulmonary-renal syndrome.
In patients who have been stabilized, the 
diagnostic evaluation should be done keep-
ing in mind that, even if DAH may result 
from a wide range of coagulation disor-
ders, hemodynamic conditions, drugs, tox-
ins and infections, up to one third of the 
cases is caused by pulmonary capillaritis 
due to systemic vasculitis and autoim-
mune collagen vascular disease, most often 
ANCA-associated vasculitis and systemic 
lupus erythematosus. Other rheumatologic 
diseases, among which Henoch-Schönlein 
purpura, rheumatoid arthritis, scleroderma, 
primary antiphospholipid syndrome and 
Behçet’s disease may be cause of DAH. It 
is interesting to notice that DAH may be 
the first, often catastrophic, manifestation 
of the underlying disorder, with up to 20% 
of patients newly diagnosed during their 
intensive care unit admission (5). There-
fore, clinicians should always keep in mind 
they might be facing the onset of a rheu-
matologic disorder, when a patient presents 
with DAH. Search for ANCA, antiglomer-
ular basement membrane antibodies and 
markers of collagen vascular diseases are 
mandatory. 
Transbronchial or open-lung biopsy may 
recognize three main histologic patterns: 
the most common one is pulmonary cap-
illaritis with leading neutrophilic compo-
nent; the second is diffuse alveolar dam-
age; the third, uncommon, pattern consists 
in hemorrhage into alveolar spaces with-
out any sign of alveolar damage (usually 
observed in cases with bland pulmonary 
hemorrhage due to anticoagulant therapy, 
pulmonary hypertension or Goodpasture’s 
syndrome).
High-dose corticosteroids and cyclophos-
Table I - reported cases of Behçet’s with small vessel pulmonary vasculitis and alveolar hemorrhage, by author.
author age/gender
IsG criteria at 
onset of alveolar 
hemorrhage
symptoms/signs Histology Outcome
tüzün et al. (7) 41/M oU, GU Hemoptysis, dyspnea, chest pain
Lobular pneumonitis, intra-alveolar 
hemorrhage, mononuclear cell 
infiltration 
Death due to massive 
hemoptysis
Koga et al. (8) 21/F oU, GU, UV
asymptomatic 
pulmonary infiltrates on 
chest x-ray
Venulitis with mononuclear cells 
infiltration
pulmonary infiltrates 
evanesced after 
immunosuppressive therapy
Uzun et al. (9) 35/F IsG fulfilled (not specified)
cough, hemoptysis, 
chest pain, dyspnea, 
sputum
Not performed
pulmonary infiltrates 
evanesced after therapy with 
colchicine
Gamble et al. (10) 58/F oU (remote history of UV, eN)
cough, fever, weight 
loss
capillaritis with polymorphonuclear 
leukocytes infiltration
pulmonary infiltrates 
evanesced after high dose 
steroid therapy
ota et al. (11) 34/M oU, GU, UV cough, fever, sputum Necrotizing granulomatous arteritis
Death due to pulmonary 
thrombo-embolism and 
massive hemorrhage
efthimiou et al. (12) 25/F oU, GU, eN, pt
cough, hemoptysis, 
pleuric chest pain, 
dyspnea
Necrotizing vasculitis (involving 
arteries) with predominance of 
mononuclear cells infiltration
Death due to massive 
hemorrhage
our case 70/M oU cough, fever, dyspnea, chest pain
Necrotizing vasculitis (involving 
arterioles, capillaries and venules) 
with neutrophilic infiltration
Death due to massive 
hemorrhage
oU, recurrent oral ulceration; GU, recurrent genital ulceration; UV, anterior or posterior uveitis; eN, erythema nodosum; pt, positive 
pathergy test; IsG, International study Group criteria for Behçet’s disease.
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phamide are the leading therapy for the 
DAH syndrome associated with systemic 
vasculitis, autoimmune connective tissue 
diseases, Goodpasture’s syndrome, and 
isolated pulmonary capillaritis, after infec-
tious etiology has been ruled out. Plasma-
pheresis has been described as useful in 
several cases, but with no effects on mor-
tality.
In this case report, the clinical course was 
too quick and severe to make a clear diag-
nosis and to start appropriate treatment. 
Given the presence of recurrent oral aph-
thosis, back acne, HLA-B51 positivity 
and arthralgia, high degree of suspicion 
remains on the diagnosis of Behçet’s dis-
ease even if our patient did not fulfill the 
International Study Group (ISG) criteria 
for Behçet’s disease (6).
Behçet’s disease is a known, though rare, 
cause of alveolar hemorrhage, resulting 
from acute inflammatory destruction of 
pulmonary arteries, rupture of PAA, pul-
monary infarcts, erosion of pulmonary 
aneurysms into adjacent bronchi or lung 
vessel vasculitis. Small vessel pulmonary 
vasculitis (arteritis, capillaritis or venulitis) 
causing alveolar hemorrhage was reported 
in 6 cases of Behçet’s disease to date (Tab. 
I) (7-12). Clinical presentations varied 
from different patterns of vasculitis alone, 
vasculitis with thrombus formation and one 
case started as a pulmonary mass lesion.
Noticeably in some of these cases, this one 
included, pulmonary vessel disease oc-
curred in the absence of ISG criteria of Be-
hçet’s disease (6), thus correct classifica-
tion remains unclear and the diagnosis was 
made on the basis of an expert’s opinion or 
with different sets of criteria.
This case illustrates the importance of a 
high level of clinical vigilance required to 
promptly suspect DAH and the difficulties 
related with its differential diagnosis.
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